A Prospective Analysis of Positron Emission Tomography and Conventional Imaging for Detection of Stage IV Metastatic Melanoma in Patients Undergoing Metastasectomy
- 1 August 2004
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 11 (8) , 731-738
- https://doi.org/10.1245/aso.2004.01.023
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patientsAnnals of Surgical Oncology, 2002
- Positron emission tomography for staging and management of malignant melanomaBritish Journal of Surgery, 2002
- Does Complete Resection of Melanoma Metastatic to Solid Intra-Abdominal Organs Improve Survival?Annals of Surgical Oncology, 2001
- MRA in patients with cerebrovascular disease: Considerations of clinical effectivenessActa Radiologica, 2000
- PET and [18F]-FDG in oncology: A clinical updateNuclear Medicine and Biology, 1996
- Positron emission tomography in the detection and management of metastatic melanomaMelanoma Research, 1996
- Positron Emission Tomography and UltrasonographyArchives of Dermatology, 1995
- Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanomaArchives of Dermatology, 1995
- Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1995
- Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucoseBritish Journal of Dermatology, 1995